Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.780
-0.035 (-1.24%)
Nov 21, 2024, 1:42 PM EST - Market open
Galectin Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -45.08 | -41.07 | -38.78 | -30.53 | -23.47 | -13.29 | |
| Depreciation & Amortization | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | |
| Stock-Based Compensation | 2.35 | 2.26 | 2.87 | 2.08 | 1.8 | 1.68 | |
| Other Operating Activities | 2.12 | 1.13 | -0.15 | 0.15 | 0.09 | 0.09 | |
| Change in Accounts Payable | 3.52 | 2.67 | 4.24 | 3.69 | 2.54 | 1 | |
| Change in Other Net Operating Assets | 3.37 | 2.01 | 0.72 | 0.27 | -1.59 | -0.36 | |
| Operating Cash Flow | -33.68 | -32.97 | -31.06 | -24.31 | -20.6 | -10.85 | |
| Long-Term Debt Issued | - | 30 | 10 | 30 | - | - | |
| Net Debt Issued (Repaid) | 40 | 30 | 10 | 30 | - | - | |
| Issuance of Common Stock | 0.38 | 10.03 | - | 6.81 | 0.26 | 50.47 | |
| Preferred Dividends Paid | - | - | - | - | - | -0.39 | |
| Dividends Paid | - | - | - | - | - | -0.39 | |
| Financing Cash Flow | 40.38 | 40.03 | 10 | 36.81 | 0.26 | 50.08 | |
| Net Cash Flow | 6.7 | 7.07 | -21.06 | 12.51 | -20.34 | 39.23 | |
| Free Cash Flow | -33.68 | -32.97 | -31.06 | -24.31 | -20.6 | -10.85 | |
| Free Cash Flow Per Share | -0.54 | -0.55 | -0.52 | -0.42 | -0.36 | -0.21 | |
| Levered Free Cash Flow | -21.47 | -20.68 | -17.56 | -13.23 | -11.89 | -6.21 | |
| Unlevered Free Cash Flow | -18.56 | -18.93 | -16.91 | -12.92 | -11.84 | -6.16 | |
| Change in Net Working Capital | -3.87 | -2.57 | -4.16 | -3.82 | -0.98 | -0.52 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.